Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial - Folegatti, P M; Bittaye, M; Flaxman, A (Lancet Infect Dis, 2020)